Research shows that children with atopic dermatitis who received both a probiotic supplement and tacrolimus ointment showed greater skin improvement than those using the cream alone. In a 2026 study of 92 children, the combination group’s eczema severity score dropped by 29.2 points compared to 23.7 points in the cream-only group after 12 weeks. Additionally, 83% of children receiving both treatments showed significant improvement versus 61% receiving tacrolimus alone. However, this single-center study needs confirmation with larger trials before becoming standard practice.
Researchers studied 92 children with atopic dermatitis, a common type of eczema that causes itchy, inflamed skin. Some children received a special skin cream called tacrolimus, while others received the same cream plus an oral probiotic supplement. According to Gram Research analysis, the children who got both treatments showed greater improvement in their skin symptoms after 12 weeks compared to those using the cream alone. The combination group had a 5.5-point greater reduction in their eczema severity score, and 83% of them showed significant improvement versus 61% in the cream-only group. However, researchers note that this single-center study needs to be confirmed with larger, longer-term trials before making firm recommendations.
Key Statistics
A 2026 single-center cohort study of 92 children found that combining an oral probiotic with tacrolimus ointment reduced atopic dermatitis severity by 29.2 points compared to 23.7 points with tacrolimus alone after 12 weeks.
In a 2026 study of 92 children with atopic dermatitis, 83% of those receiving both probiotics and tacrolimus showed significant improvement compared to 61% receiving tacrolimus alone.
A 2026 cohort study found that children receiving combined probiotic and tacrolimus treatment were 2.76 times more likely to show significant clinical improvement in atopic dermatitis than those receiving tacrolimus alone.
The Quick Take
- What they studied: Whether adding a probiotic supplement to a standard eczema skin cream helps children with atopic dermatitis improve faster and more completely than using the cream alone.
- Who participated: 92 children with atopic dermatitis treated at a single medical center between March 2023 and March 2025. The children were divided into two groups: one receiving tacrolimus ointment alone, and another receiving tacrolimus ointment plus an oral probiotic preparation.
- Key finding: Children receiving both the probiotic and tacrolimus cream showed greater skin improvement after 12 weeks. Their eczema severity score dropped by an average of 29.2 points compared to 23.7 points in the cream-only group. Additionally, 83% of the combination group showed significant improvement versus 61% of the cream-only group.
- What it means for you: Adding probiotics to standard eczema treatment may help children heal faster, but this is preliminary evidence from a single center. Parents should discuss this option with their child’s dermatologist. Larger studies are needed before this becomes standard practice. The improvement seen was modest and may not be noticeable to all families.
The Research Details
This was a retrospective cohort study, meaning researchers looked back at medical records of children who had already received treatment. They compared two groups: children who received tacrolimus ointment alone versus children who received tacrolimus ointment plus an oral probiotic. To make the groups as similar as possible at the start, researchers used a statistical technique called propensity score matching. This method accounts for differences in age, sex, disease severity, allergy history, and other factors that might affect outcomes. The researchers then compared how much each group’s eczema improved over 12 weeks.
The study used a special scoring system called SCORAD to measure eczema severity before and after treatment. SCORAD considers how much skin is affected, how intense the symptoms are, and how much the condition bothers the child. The researchers also measured three immune system markers in the blood: total immunoglobulin E, interleukin-4, and leukotriene B4. These markers help show how active the immune system’s allergic response is.
Because this was a retrospective study looking at past medical records rather than a controlled experiment, the researchers had to be careful about confounding variables, which are factors that might influence results besides the treatment itself. They used statistical methods to reduce this bias, but some unmeasured factors could still have affected the findings.
Atopic dermatitis affects millions of children and significantly impacts quality of life through itching, sleep disruption, and infection risk. Current standard treatments like tacrolimus work well for many children, but some still struggle with persistent symptoms. If probiotics can enhance treatment effectiveness, this would offer families a relatively safe, non-invasive option to improve outcomes. Understanding how probiotics might work through immune system markers could help researchers develop better combination therapies. However, because this is a single-center study with a small sample size, the findings need confirmation in larger, more rigorous trials before changing clinical practice.
This study has several strengths: it used propensity score matching to reduce bias, measured objective outcomes using a validated severity scale, and assessed immune markers to understand potential mechanisms. However, there are important limitations. It’s a retrospective study, meaning researchers relied on existing medical records rather than carefully controlling conditions. The sample size of 92 children is relatively small. The study lasted only 12 weeks, so we don’t know if benefits persist longer. Most importantly, this was a single-center study, so results may not apply to other populations or treatment settings. The researchers themselves note that the improvement seen, while statistically significant, was smaller than what patients typically notice clinically.
What the Results Show
In the original group of 92 children, those receiving both probiotics and tacrolimus showed greater improvement than those receiving tacrolimus alone. The combination group’s eczema severity score decreased by an average of 29.2 points compared to 23.7 points in the tacrolimus-only group, a difference of 5.5 points. This difference was statistically significant, meaning it’s unlikely to have occurred by chance.
When measuring clinical response, defined as at least a 50% improvement in eczema severity, 83% of children in the combination group showed this level of improvement compared to 61% in the tacrolimus-only group. This 22-percentage-point difference was also statistically significant.
When researchers used propensity score matching to create more balanced comparison groups, the combination therapy remained associated with better clinical response. Children receiving both treatments were 2.76 times more likely to show significant improvement than those receiving tacrolimus alone. This finding held up even when researchers adjusted for additional factors like food allergies and secondhand smoke exposure.
The researchers also measured immune system markers in the blood, though the abstract doesn’t provide detailed results for these measurements. These markers help indicate how active the allergic immune response is in children with eczema.
The study assessed safety and tolerability of the combination treatment, though specific adverse event data isn’t detailed in the abstract. The fact that researchers could successfully match 38 pairs of children with similar baseline characteristics suggests the propensity score method worked well to reduce confounding. The consistency of results across different statistical analyses (original cohort, propensity-matched cohort, and multivariable-adjusted model) suggests the findings are relatively robust to different analytical approaches.
This study adds to growing evidence that probiotics may have a role in managing atopic dermatitis. Previous research has suggested that gut bacteria influence immune system development and allergic responses. However, most prior studies have been small or had methodological limitations. This study is notable for using propensity score matching to reduce bias, a more rigorous approach than many earlier probiotic studies. The findings align with the biological plausibility that probiotics could modulate immune responses, but the magnitude of benefit is modest compared to some earlier reports.
The researchers themselves identify several important limitations. First, this is a retrospective study based on medical records, not a prospective randomized controlled trial, which is the gold standard for testing treatments. Second, the sample size of 92 children is relatively small, limiting statistical power. Third, the study lasted only 12 weeks, so we don’t know if benefits continue, diminish, or reverse over longer periods. Fourth, this was a single-center study, so results may not apply to other hospitals or populations. Fifth, the improvement seen, while statistically significant, was 5.5 points on the SCORAD scale, which is smaller than the 8.7-point difference that patients typically notice clinically. Sixth, unmeasured confounding cannot be excluded, meaning unknown factors could have influenced results. Finally, the specific probiotic formulation used in this study may not be the same as other probiotic products available commercially.
The Bottom Line
Based on this single-center cohort study, adding a probiotic supplement to standard tacrolimus treatment may help children with atopic dermatitis improve faster over 12 weeks. However, confidence in this recommendation is moderate because the study has significant limitations. Parents should discuss probiotic use with their child’s dermatologist before starting, as the specific formulation matters and individual responses vary. This should not replace standard treatments like tacrolimus or other prescribed medications. Larger, longer-term randomized controlled trials are needed before probiotics become standard adjunctive therapy.
This research is most relevant to parents of children with moderate to severe atopic dermatitis who are already using or considering tacrolimus treatment. Children with food allergies or other immune conditions should discuss probiotics with their doctor first. This is less relevant to children with mild eczema controlled by basic moisturizers and occasional topical steroids. Adults with atopic dermatitis should not assume these results apply to them, as children’s immune systems differ from adults’. Healthcare providers treating pediatric atopic dermatitis should be aware of this evidence but should wait for larger trials before routinely recommending probiotics.
If a child were to start this combination treatment, the study shows that measurable improvement in eczema severity typically appears within 12 weeks. However, some children may see benefits sooner, while others may take longer. The study doesn’t provide information about how long benefits persist after stopping treatment or whether continued probiotic use is necessary. Individual responses vary significantly, so some children may see dramatic improvement while others notice minimal change.
Frequently Asked Questions
Can probiotics help my child’s eczema get better faster?
Research suggests that adding probiotics to standard eczema cream may help some children improve faster. A 2026 study found 83% of children receiving both treatments showed significant improvement versus 61% with cream alone. However, this needs confirmation in larger studies before becoming standard practice.
What is the difference between using tacrolimus alone versus tacrolimus with probiotics for eczema?
In a 2026 study of 92 children, the combination of tacrolimus and probiotics reduced eczema severity by 5.5 points more than tacrolimus alone over 12 weeks. While statistically significant, this difference is smaller than what families typically notice clinically.
How long does it take to see improvement from probiotics and eczema cream?
The 2026 study measured improvement over 12 weeks, when 83% of children receiving both treatments showed significant improvement. Individual children may see benefits sooner or take longer, as responses vary considerably.
Are probiotics safe for children with atopic dermatitis?
The 2026 study assessed safety of the combination treatment, though specific adverse event details weren’t provided. Parents should discuss probiotic use with their child’s dermatologist, especially if the child has food allergies or other immune conditions.
Should I replace my child’s eczema medication with probiotics?
No. Probiotics should not replace prescribed eczema treatments like tacrolimus. The research suggests probiotics may help enhance standard treatment, not replace it. Always consult your child’s dermatologist before making changes to treatment.
Want to Apply This Research?
- Track weekly eczema severity using a simple 0-10 scale rating itchiness, redness, and affected skin area. Also note sleep disruption caused by itching and any visible skin improvements. This allows families to see patterns and share objective data with their dermatologist.
- If starting this combination approach, set a reminder to take the probiotic supplement at the same time daily and apply tacrolimus ointment as prescribed. Use the app to log when treatments are taken and photograph the same skin areas weekly to visually track changes over time.
- Over 12 weeks, track SCORAD-like measurements weekly using the app’s symptom logger. Create a photo timeline of affected skin areas taken in consistent lighting. Monitor for any adverse reactions or side effects. After 12 weeks, review trends with your dermatologist to decide whether to continue, adjust, or discontinue the probiotic supplement based on your child’s individual response.
This article summarizes research findings but is not medical advice. Atopic dermatitis treatment should always be guided by a qualified dermatologist or pediatrician. The study described is a single-center retrospective cohort study with a small sample size and 12-week duration, so results may not apply to all children or populations. The specific probiotic formulation used in this study may differ from commercial products. Before starting any new treatment, including probiotics, consult your child’s healthcare provider, especially if your child has food allergies, immune conditions, or takes other medications. Individual responses to treatment vary significantly.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.